BRIEF published on 03/20/2024 at 18:05, 1 year 8 months ago Important Changes to the Guerbet Board of Directors Board Of Directors Pharmaceutical Guerbet Medical Imaging Hugues Lecat
BRIEF published on 03/20/2024 at 18:05, 1 year 8 months ago Changements Importants au Conseil d'Administration de Guerbet Conseil D'administration Guerbet Imagerie Médicale Hugues Lecat Pharmaceutique
PRESS RELEASE published on 03/20/2024 at 18:00, 1 year 8 months ago Guerbet: Change in Guerbet’s Board of Directors. Guerbet appoints Hugues Lecat as a non-voting director with plans for him to become Chairman, enhancing the company's governance and strategic vision for future success Board Of Directors Guerbet Medical Imaging Chairman Appointment Hugues Lecat
PRESS RELEASE published on 03/20/2024 at 18:00, 1 year 8 months ago Guerbet: Evolution du Conseil d’Administration de Guerbet. Annonce de l'évolution du Conseil d'Administration de Guerbet avec la nomination de Hugues Lecat en qualité de censeur et futur Président, et déclarations des principaux intéressés Assemblée Générale Conseil D'administration Guerbet Imagerie Médicale Hugues Lecat
BRIEF published on 03/20/2024 at 17:50, 1 year 8 months ago Guerbet annonce une croissance solide et une rentabilité améliorée pour ses résultats annuels 2023 Résultats Financiers Rentabilité Guerbet Imagerie Médicale Croissance 2023
BRIEF published on 03/20/2024 at 17:50, 1 year 8 months ago Guerbet Announces Solid Growth and Improved Profitability in 2023 Full-Year Results Financial Results Profitability Guerbet Healthcare Imaging 2023 Growth
PRESS RELEASE published on 03/20/2024 at 17:45, 1 year 8 months ago Guerbet: Résultats annuels 2023. Publication des résultats annuels 2023 de Guerbet avec une croissance solide de l’activité et une rentabilité supérieure aux objectifs. Perspectives 2024 confirmées avec prévisions de croissance et rentabilité en hausse Croissance Perspectives 2024 Guerbet Résultats Annuels Rentabilité
PRESS RELEASE published on 03/20/2024 at 17:45, 1 year 8 months ago Guerbet: 2023 full-year results. Guerbet publishes solid 2023 full-year results with revenue growth of 5.9% at CER and EBITDA margin exceeding target. Confirms outlook for 2024 with revenue growth > 8% and higher profitability Revenue Growth 2024 Outlook EBITDA Margin Guerbet 2023 Full-year Results
BRIEF published on 03/11/2024 at 08:05, 1 year 8 months ago Guerbet annonce des nominations clés pour dynamiser sa stratégie à long terme Innovation Nominations Guerbet Imagerie Médicale Stratégie À Long Terme
BRIEF published on 03/11/2024 at 08:05, 1 year 8 months ago Guerbet announces key appointments to boost its long-term strategy Innovation Appointments Guerbet Medical Imaging Long-term Strategy
Published on 12/05/2025 at 02:35, 6 hours 47 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 22 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 17 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 22 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 17 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 37 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 37 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 40 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 7 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 22 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
